GlycoMimetics, Inc.
USD15.71
-0.45 (-2.76%)
CEO
Stephanie R. Irish CPA
IPO Date
2014-01-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.25
Prev. Close
$16.15
Day Low
$15.52
Day High
$17.39
52W Low
$0.15
52W High
$63.00
Market Cap
$1.01B
Volume
0.00M
| 260,873 |
| $0.19 |
| 7 Aug 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 164,523 | $0.19 |
| 7 Aug 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 55,732 | $0.18 |
| 5 Aug 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 63,564 | $0.22 |
| 5 Aug 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 286,200 | $0.20 |
| 30 Jul 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 258,335 | $0.24 |
| 30 Jul 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 363,949 | $0.24 |
| 30 Jul 2024 | Invus Public Equities, L.P. | 10 percent owner | S-Sale | Disposed | 756,835 | $0.22 |
| 20 Jun 2024 | Hahn Brian M. | SVP Finance, CFO | P-Purchase | Acquired | 17,500 | $0.25 |